Yves Levy,1 the data demonstrate the ability of ... novel class of immunotherapy fusing the power of antibodies and vaccines. AMV candidates engage, prime and activate Dendritic Cells in vivo ...
EnnoDC presents positive Phase I data at CROI 2025, demonstrating long-lasting immunity induced by Antibody Mediated Vaccines (AMVs)Findings in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback